Sipcam Nichino Brasil Unveils Soleado Fungicide at Hortitec 2025
At Hortitec 2025, Latin America’s largest horticulture event, Sipcam Nichino Brasil pre-launched its new fungicide Soleado, featuring amisulbrom as the active ingredient. The product, formulated as a water-dispersible granule (WG), is set to hit the market in the coming weeks.
Soleado is a systemic fungicide designed to combat black spot and leaf spot diseases across a wide range of crops. It is registered for use on over 20 crops, including tomatoes, strawberries, onions, carrots, potatoes, peppers, spinach, and roses, among others. This versatility makes it an essential tool for growers facing diverse plant diseases.
In addition to Soleado, Sipcam Nichino showcased its highly successful insecticide Ohkami, which has gained popularity in Brazil’s tomato sector. Known for its exceptional control of pests such as leafminers, thrips, mites, and tomato fruit borers, Ohkami has also been applied to other 11 crops, including broccoli, kale, and cauliflower, where it excels against diamondback moths.
The company also highlighted its Pulsor 240 SC fungicide, which has demonstrated strong results in combating potato diseases, particularly black scurf (Rhizoctoniosis). Pulsor 240 SC provides both preventive and curative action, effectively targeting multiple stages of Rhizoctonia solani infections. It is also approved for disease management in coffee, chrysanthemums, and turfgrass, making it a valuable solution across multiple sectors.
Looking for chemical products? Let suppliers reach out to you!
2026-07-19
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
-
FDA Orders Removal of “Suicidality Warning”: Are Weight-Loss Blockbusters Finally Cleared—or Is Regulators Giving the Market a Reality Check?
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Novo Nordisk Sounds the Alarm: Growth Headwinds Loom Over Global Operations in 2026
-
Lilly Eyes Fast-Track Approval for Oral Weight-Loss Drug in U.S.
Recommend Reading
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
Lupin Secures Tentative U.S. Approval for Its Multiple Sclerosis Tablet
-
The GLP-1 Sweet Shot in India’s Diabetic Gut
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
This Week China's Titanium Dioxide Market Prices Stabilize (5.11-5.15)
-
November TDI Market Rises Sharply and Then Falls
-
Mine Shutdown Drives Up Lithium Carbonate Prices
-
This Week, the Chinese Polymeric MDI Market Rebounded and Rose (5.11-5.15)
-
This week, the market price of maleic anhydride in China continues to rise